systemic lupus erythematosus

AbbVie and Lupus Therapeutics partner for SLE trial recruitment
AbbVie and Lupus Therapeutics partner for SLE trial recruitment
Clinical Trials Arena
AbbVie
Lupus Therapeutics
systemic lupus erythematosus
lupus
Rinvoq
clinical trials
Flag link:
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
Fierce Pharma
AbbVie
Rinvoq
Humira
systemic lupus erythematosus
lupus
clinical trials
Flag link:
Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023
Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023
Clinical Trials Arena
clinical trials
systemic lupus erythematosus
AbbVie
ABBV-509
Eli Lilly
LY3471851
Merck KGaA
M5049
Swedish Orphan Biovitrum
emapalumab
Flag link:
Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise
Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise
BioSpace
Biogen
litifilimab
lupus
systemic lupus erythematosus
monoclonal antibodies
clinical trials
Flag link:
Thermo Fisher's (TMO) Autoimmune Disease Test Gets FDA Nod
Thermo Fisher's (TMO) Autoimmune Disease Test Gets FDA Nod
Yahoo/Zacks.com
FDA
Thermo Fisher Scientific
diagnostics
Medtech
autoimmune disease
EliA RNA Polymerase III
EliA Rib-P
systemic sclerosis
systemic lupus erythematosus
Flag link:
AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo
AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo
Fierce Pharma
AstraZeneca
GSK
FDA
lupus
Saphnelo
systemic lupus erythematosus
Benlysta
Flag link:
One year after flop, AstraZeneca's phase 3 lupus trial hits endpoint
One year after flop, AstraZeneca's phase 3 lupus trial hits endpoint
Fierce Biotech
AstraZeneca
clinical trials
anifrolumab
systemic lupus erythematosus
lupus
Flag link:
GSK gets FDA nod for Benlysta to treat pediatric patients with lupus
GSK gets FDA nod for Benlysta to treat pediatric patients with lupus
Pharmaceutical Business Review
GSK
FDA
Benlysta
SLE
systemic lupus erythematosus
pediatrics
Flag link:
Another setback for AstraZeneca as lupus drug fails phase 3 test
Another setback for AstraZeneca as lupus drug fails phase 3 test
Fierce Biotech
AstraZeneca
SLE
systemic lupus erythematosus
lupus
anifrolumab
clinical trials
Flag link:
GSK gets go-ahead for new Benlysta formulation
GSK gets go-ahead for new Benlysta formulation
BioPharma Dive
GSK
Benlysta
systemic lupus erythematosus
SLE
Flag link: